Table 1: Characteristics
of study groups.
|
|
|
Group 1 |
Group 2 |
Group 3 |
||
|
Number of
subjects |
|
34 |
39 |
|
62 |
|
|
Mean age (yrs) |
|
35 |
48 |
|
50 |
|
|
Mean duration
gel bleed (yrs) |
|
n.a. |
15 |
|
15 |
|
|
Mean
follow-up (yrs) |
|
n.a. |
n.a. |
|
3.5 |
|
|
Capsular
contraction |
Baker 0 |
n.a. |
10 |
26% |
13 |
21% |
|
|
Baker I |
n.a. |
4 |
10% |
4 |
6% |
|
|
Baker II |
n.a. |
4 |
10% |
8 |
13% |
|
|
Baker III |
n.a. |
10 |
26% |
16 |
26% |
|
|
Baker IV |
n.a. |
11 |
28% |
21 |
34% |
|
Implant |
Ruptured |
n.a. |
22 |
56% |
35 |
56% |
|
|
Intact |
n.a. |
15 |
39% |
27 |
44% |
|
|
Unknown |
n.a. |
2 |
5% |
0 |
0% |
|
Generation of
implant |
Type 1 |
n.a. |
1 |
3% |
1 |
2% |
|
|
Type 2 |
n.a. |
2 |
5% |
18 |
29% |
|
|
Type 3 |
n.a. |
23 |
59% |
43 |
69% |
|
|
Type 4 |
n.a. |
13 |
33% |
0 |
0% |
|
|
Type 5 |
n.a. |
0 |
0% |
0 |
0% |
|
Complaints |
|
n.a. |
27 |
69% |
55 |
89% |